Advanced search

Results from the international, randomized phase 3 study of ibrutinib versus chlorambucil in patients 65 years and older with treatment-naive (TN) CLL/SLL (RESONATE-2 (TM))

(2016) BRITISH JOURNAL OF HAEMATOLOGY. 173(suppl. 1). p.7-7
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Hillmen, P, A Tedeschi, PM Barr, T Robak, C Owen, P Ghia, O Bairey, et al. 2016. “Results from the International, Randomized Phase 3 Study of Ibrutinib Versus Chlorambucil in Patients 65 Years and Older with Treatment-naive (TN) CLL/SLL (RESONATE-2 (TM)).” In British Journal of Haematology, 173:7–7.
APA
Hillmen, P, Tedeschi, A., Barr, P., Robak, T., Owen, C., Ghia, P., Bairey, O., et al. (2016). Results from the international, randomized phase 3 study of ibrutinib versus chlorambucil in patients 65 years and older with treatment-naive (TN) CLL/SLL (RESONATE-2 (TM)). BRITISH JOURNAL OF HAEMATOLOGY (Vol. 173, pp. 7–7). Presented at the 36th World congress of the International Society of Hematology.
Vancouver
1.
Hillmen P, Tedeschi A, Barr P, Robak T, Owen C, Ghia P, et al. Results from the international, randomized phase 3 study of ibrutinib versus chlorambucil in patients 65 years and older with treatment-naive (TN) CLL/SLL (RESONATE-2 (TM)). BRITISH JOURNAL OF HAEMATOLOGY. 2016. p. 7–7.
MLA
Hillmen, P, A Tedeschi, PM Barr, et al. “Results from the International, Randomized Phase 3 Study of Ibrutinib Versus Chlorambucil in Patients 65 Years and Older with Treatment-naive (TN) CLL/SLL (RESONATE-2 (TM)).” British Journal of Haematology. Vol. 173. 2016. 7–7. Print.
@inproceedings{7249289,
  articleno    = {abstract 4},
  author       = {Hillmen, P and Tedeschi, A and Barr, PM and Robak, T and Owen, C and Ghia, P and Bairey, O and Bartlett, NL and Li, J and Simpson, D and Grosicki, S and Devereux, S and McCarthy, H and Coutre, S and Quach, H and Gaidano, G and Maslyak, Z and Stevens, DA and Janssens, A and Offner, Fritz and Mayer, J and O'Dwyer, M and Hellmann, A and Schuh, A and Siddiqi, T and Pollack, A and Tam, CS and Suri, D and Zhou, C and Clow, F and Styles, L and James, DF and Kipps, TJ and Burger, JA},
  booktitle    = {BRITISH JOURNAL OF HAEMATOLOGY},
  issn         = {0007-1048},
  language     = {eng},
  location     = {Glasgow, Scotland, UK},
  number       = {suppl. 1},
  pages        = {abstract 4:7--abstract 4:7},
  title        = {Results from the international, randomized phase 3 study of ibrutinib versus chlorambucil in patients 65 years and older with treatment-naive (TN) CLL/SLL (RESONATE-2 (TM))},
  volume       = {173},
  year         = {2016},
}

Web of Science
Times cited: